Scarica l'app Stockscreener
4.48
1.13%
0.05
Dopo l'orario di chiusura:
4.48
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BHC Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Bausch Health Companies Inc Borsa (BHC) Ultime notizie
Bausch Health Companies Inc expected to post earnings of $1.04 a shareEarnings Preview - TradingView
Bausch Health (TSX:BHC) Maps Out A Fresh Pharma Roadmap - Kalkine Media
Bausch Health Companies Inc (BHC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Bausch Health Companies Inc (BHC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Zacks Research Cuts Earnings Estimates for Bausch Health Cos - MarketBeat
Bausch Health Companies Inc - TradingKey
Healthcare of Ontario Pension Plan Trust Fund Sells 452,119 Shares of Bausch Health Cos Inc. $BHC - MarketBeat
BHC|Bausch Health Companies Inc|Price:4.430|Chg%:-0.015 - TradingKey
Bausch Health Companies Inc (BHC) Institutional Confidence - TradingKey
Bausch Health Cos (NYSE:BHC) Upgraded by Jefferies Financial Group to Hold Rating - MarketBeat
Why Bausch Health (TSX:BHC) Draws Fresh Attention Today? - Kalkine Media
Bausch Health stock trades steadily as debt reduction and Xifaxan growth shape the outlook - Ad-hoc-news.de
RBC Capital Maintains Bausch Health(BHC.US) With Hold Rating, Maintains Target Price $9 - Moomoo
Bausch Health Poised to Report Q2 Consolidated Revenue of $2.73 Billion, RBC Capital Markets Says - Moomoo
Bausch Health (TSX:BHC) Charts Fresh Pharma Roadmap - Kalkine Media
Bausch Health Cos (NYSE:BHC) Reaches New 52-Week LowShould You Sell? - MarketBeat
Bausch Health Companies stock hits 52-week low at $4.56 By Investing.com - Investing.com South Africa
Bausch Health Companies stock hits 52-week low at $4.56 - Investing.com
Bausch Health Companies Inc. (BHC) Stock Analysis: Potential 58% Upside Draws Investor Attention - DirectorsTalk Interviews
Bausch Health (NYSE: BHC) exec has 5,260 shares withheld for taxes - Stock Titan
Bausch + Lomb launches AI-powered digital health platform By Investing.com - Investing.com Nigeria
Bausch Health stock holds as debt and revenue metrics stay central - AD HOC NEWS
BHC4928364 Bond Profile — Key Metrics - TradingView
Bausch Health (NYSE: BHC) withholds 23,395 shares for RSU tax obligations - Stock Titan
Bausch Health Companies (TSX:BHC) Charts Pharma Path - Kalkine Media
Bausch + Lomb launches EyeGility IOL delivery system in U.S. By Investing.com - Investing.com Australia
BHC4986567 Bond Profile — Key Metrics - TradingView
Bausch + Lomb Launches EyeGility™ Inserter Preloaded IOL Delivery System in the United States - Financial Times
Bausch + Lomb launches EyeGility IOL delivery system in U.S. - Investing.com UK
Bausch Health Companies (NYSE: BHC) CAO reports 3,125-share tax withholding - Stock Titan
BHC5524410 Bond Profile — Key Metrics - TradingView
Why Is Bausch Health Companies (TSX:BHC) Back In Focus? - Kalkine Media
Bausch Health’s (BHC) Canadian Subsidiary Lists PrOKEDI Dosages in RAMQ Formulary - Yahoo Finance
Bausch Health stock reflects a complex turnaround story for investors - AD HOC NEWS
WELL Health Technologies (TSX:WELL) Anchors Digital Health Market Watch - Kalkine Media
Bausch Health: Can BHC Execute a Drop Down Transaction to Refinance BHC First Lien Bonds? - CreditSights
Bausch + Lomb halts glaucoma eye drop program after trial miss - Investing.com UK
Bausch + Lomb launches AI-powered digital health platform - Investing.com
Bausch Health Companies updates its path in pharmaceuticals as investors watch broader sector trends - ad-hoc-news.de
Bausch Health's Aesthetic Business, Solta Medical, Earns Prestigious Trademark Certification of Thermage® in China - AOL.com
Migraine Pipeline 2026: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | GlaxoSmithKline, Merck, Pfizer, Bausch Health, Amgen, Abbvie, AstraZeneca, Eli Lilly - Barchart.com
Bausch Health Charts Its Next Move In Specialty Pharma - Kalkine Media
Bausch Health Companies Inc. - Baystreet.ca
Stocks in play: Bausch Health Companies Inc. - The Globe and Mail
Bausch Health plans July 29 call for Q2 results and business update - Stock Titan
Bausch Health to Announce Second Quarter 2026 Results on July 29, 2026 - Moomoo
Bausch Health to report Q2 2026 earnings on Jul... - Pluang
BHC Stock Price Prediction 2025-2026 | Bausch Health Companies Inc Forecast - 24/7 Wall St.
Bausch Health Continues Specialty Pharma Strategy In 6 July 2026 - Kalkine Media
Why Did Bausch Health (TSX:BHC) Announce a Board Change? - Kalkine Media
Québec is the first province to list (Pr)OKEDI(MC) (extended-release injectable suspension of risperidone) on the public drug reimbursement formulary for the treatment of schizophrenia - PR Newswire Canada
Bausch Health Companies (BHC) Posts Modest Gain, Tests Resistance ZoneBeta Neutral Pair - dars.gov.et
Bausch Health (BHC) director granted RSUs in lieu of cash fees - Stock Titan
Bausch Health (NYSE: BHC) director John Paulson granted 12,677 RSUs as board pay - Stock Titan
Bausch Health (NYSE: BHC) director granted 6,845 RSUs as board compensation - Stock Titan
Bausch Health (TSX:BHC) Board Change Follows Director Resignation - Kalkine Media
Best TSX Healthcare Stocks to Watch for July 2026 - Kalkine Media
Bausch Health Companies Inc. Files 8-K Announcing Leadership Change and Company Overview (June 26, 2026) - Minichart
Michael Goettler Resigns from Bausch Health's Board of Directors - GuruFocus
Director Michael Goettler exits Bausch Health (NYSE: BHC) board - Stock Titan
Bausch + Lomb survey finds dry eye affects emotional health - Investing.com
Bausch + Lomb survey finds dry eye affects emotional health By Investing.com - Investing.com South Africa
0.30%
2.01%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):